Similar articles for PMID: 24666287

Year	Number of Results
1976	1
1985	1
1996	1
1999	1
2001	2
2002	1
2004	3
2005	2
2006	2
2007	9
2008	6
2009	11
2010	17
2011	35
2012	32
2013	42
2014	30
2015	36
2016	38
2017	33
2018	31
2019	33
2020	37
2021	22
2022	5
2023	8
2024	0

1

Synthesis and in vitro and in vivo evaluation of SiFA-tagged bombesin and RGD peptides as tumor imaging probes for positron emission tomography.

Lindner S, Michler C, Leidner S, Rensch C, Wängler C, Schirrmacher R, Bartenstein P, Wängler B. Lindner S, et al. Bioconjug Chem. 2014 Apr 16;25(4):738-49. doi: 10.1021/bc400588e. Epub 2014 Apr 4. Bioconjug Chem. 2014. PMID: 24666287

2

Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.

Richter S, Wuest M, Krieger SS, Rogers BE, Friebe M, Bergmann R, Wuest F. Richter S, et al. Nucl Med Biol. 2013 Nov;40(8):1025-34. doi: 10.1016/j.nucmedbio.2013.07.005. Epub 2013 Aug 19. Nucl Med Biol. 2013. PMID: 23969085

3

One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET).

Wängler C, Waser B, Alke A, Iovkova L, Buchholz HG, Niedermoser S, Jurkschat K, Fottner C, Bartenstein P, Schirrmacher R, Reubi JC, Wester HJ, Wängler B. Wängler C, et al. Bioconjug Chem. 2010 Dec 15;21(12):2289-96. doi: 10.1021/bc100316c. Epub 2010 Nov 17. Bioconjug Chem. 2010. PMID: 21082773

4

Next Generation of SiFAlin-Based TATE Derivatives for PET Imaging of SSTR-Positive Tumors: Influence of Molecular Design on In Vitro SSTR Binding and In Vivo Pharmacokinetics.

Litau S, Niedermoser S, Vogler N, Roscher M, Schirrmacher R, Fricker G, Wängler B, Wängler C. Litau S, et al. Bioconjug Chem. 2015 Dec 16;26(12):2350-9. doi: 10.1021/acs.bioconjchem.5b00510. Epub 2015 Oct 14. Bioconjug Chem. 2015. PMID: 26420336

5

In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.

Niedermoser S, Chin J, Wängler C, Kostikov A, Bernard-Gauthier V, Vogler N, Soucy JP, McEwan AJ, Schirrmacher R, Wängler B. Niedermoser S, et al. J Nucl Med. 2015 Jul;56(7):1100-5. doi: 10.2967/jnumed.114.149583. Epub 2015 May 14. J Nucl Med. 2015. PMID: 25977461 Free article.

6

Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS. Chen X, et al. J Nucl Med. 2004 Oct;45(10):1776-83. J Nucl Med. 2004. PMID: 15471848 Free article.

7

(18)F-glyco-RGD peptides for PET imaging of integrin expression: efficient radiosynthesis by click chemistry and modulation of biodistribution by glycosylation.

Maschauer S, Haubner R, Kuwert T, Prante O. Maschauer S, et al. Mol Pharm. 2014 Feb 3;11(2):505-15. doi: 10.1021/mp4004817. Epub 2013 Dec 16. Mol Pharm. 2014. PMID: 24325589

8

Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis.

Dumont RA, Deininger F, Haubner R, Maecke HR, Weber WA, Fani M. Dumont RA, et al. J Nucl Med. 2011 Aug;52(8):1276-84. doi: 10.2967/jnumed.111.087700. Epub 2011 Jul 15. J Nucl Med. 2011. PMID: 21764795 Free article.

9

Rerouting the metabolic pathway of (18)F-labeled peptides: the influence of prosthetic groups.

Richter S, Wuest M, Bergman CN, Way JD, Krieger S, Rogers BE, Wuest F. Richter S, et al. Bioconjug Chem. 2015 Feb 18;26(2):201-12. doi: 10.1021/bc500599m. Epub 2015 Jan 26. Bioconjug Chem. 2015. PMID: 25572982

10

Metabolically Stabilized (68)Ga-NOTA-Bombesin for PET Imaging of Prostate Cancer and Influence of Protease Inhibitor Phosphoramidon.

Richter S, Wuest M, Bergman CN, Krieger S, Rogers BE, Wuest F. Richter S, et al. Mol Pharm. 2016 Apr 4;13(4):1347-57. doi: 10.1021/acs.molpharmaceut.5b00970. Epub 2016 Mar 23. Mol Pharm. 2016. PMID: 26973098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

398 results

Results by year